#0 [internal function]: __error() #1 system/modules/tabcontrol/elements/ContentTabControl.php(41): count() #2 system/modules/core/elements/ContentElement.php(265): Contao\ContentTabControl->compile() #3 system/modules/core/library/Contao/Controller.php(484): Contao\ContentElement->generate() #4 system/modules/core/modules/ModuleArticle.php(213): Contao\Controller::getContentElement() #5 system/modules/core/modules/Module.php(287): Contao\ModuleArticle->compile() #6 system/modules/core/modules/ModuleArticle.php(67): Contao\Module->generate() #7 system/modules/core/library/Contao/Controller.php(417): Contao\ModuleArticle->generate() #8 system/modules/core/library/Contao/Controller.php(277): Contao\Controller::getArticle() #9 system/modules/core/pages/PageRegular.php(133): Contao\Controller::getFrontendModule() #10 system/modules/core/controllers/FrontendIndex.php(285): Contao\PageRegular->generate() #11 index.php(20): Contao\FrontendIndex->run() #12 {main}

#0 [internal function]: __error() #1 system/modules/core/library/Contao/Template.php(294): header() #2 system/modules/core/classes/FrontendTemplate.php(121): Contao\Template->output() #3 system/modules/core/pages/PageRegular.php(190): Contao\FrontendTemplate->output() #4 system/modules/core/controllers/FrontendIndex.php(285): Contao\PageRegular->generate() #5 index.php(20): Contao\FrontendIndex->run() #6 {main}

#0 [internal function]: __error() #1 system/modules/core/library/Contao/Template.php(295): header() #2 system/modules/core/classes/FrontendTemplate.php(121): Contao\Template->output() #3 system/modules/core/pages/PageRegular.php(190): Contao\FrontendTemplate->output() #4 system/modules/core/controllers/FrontendIndex.php(285): Contao\PageRegular->generate() #5 index.php(20): Contao\FrontendIndex->run() #6 {main}

The Liver Lab

Salta la navigazione

Our friends

Chapter on book
Full Paper
Reviews and Editorials

Nonalcoholic fatty liver disease: A wide spectrum disease

Rosso N, Bellentani S

Chapter of 'Liver Diseases'

Springer book

2020

lcnRNA-mediated regulation of acquired chemoresistance in HCC

DiStefano J, Sukowati CHC

Chapter of ‘The Chemical Biology of Long Noncoding RNAs

Springer book

2020

Heterogeneity of hepatic cancer stem cells

Sukowati CHC

Chapter of 'Stem Cells Heterogeneity in Cancer"

Adv Exp Med Biol 2019, Vol. 1139 (ed: A. Birbrair)

Springer Nature

2019

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM, Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

Pagina 1 di 2

Association of bright liver with the PNPLA3 I148M gene variant in 1-year-old toddlers

Bedogni G, De Matteis G, Fabrizi M, Alisi A, Crudele A, Pizzolante F, Signore F, Dallapiccola B, Nobili V, Manco M

J Clin Endocrinol Metab. Jan 14. doi: 10.1210/jc.2018-01998

2019

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma

Pascut D, Sukowati CHC, Antoniali G, Mangiapane G, Burra S, Mascaretti LG, Buonocore MR, Crocè LS, Tiribelli C, Tell G

Oncotarget 10(3):383-394. doi: 10.18632/oncotarget.26555

2019

Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity

Pascut D, Tamini S, Bresolin S, Giraudi P, Basso G, Minocci A, Tiribelli C, Grugni G, Sartorio A

Endocr Connect. 7(12):1262-1274. doi: 10.1530/EC-18-0329

2018

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

Foschi FG, Bedogni G, Domenicali M, Giacomoni P, Dall'Aglio AC, Dazzani F, Lanzi A, Conti F, Savini S, Saini G, Bernardi M, Andreone P, Gastaldelli A, Casadei Gardini A, Tiribelli C, Bellentani S, Stefanini GF

BMC Gastroenterol. 18(1):177. doi: 10.1186/s12876-018-0906-

2018

Bilirubin-induced oxidative stress leads to DNA damage in the cerebellum of hyperbilirubinemic neonatal mice and activates DNA double strand break repair pathways in human cells

Rawat V, Bortolussi G, Gazzin S, Tiribelli C, Muro AF

Oxid Med Cell Longev 2018:1801243. doi: 10.1155/2018/1801243

2018

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat

Vianello E, Zampieri S, Marcuzzo T, Tordini F, Bottin C, Dardis A, Zanconati F, Tiribelli C, Gazzin S

Sci Rep. 8(1):13690. doi: 10.1038/s41598-018-32106-w

2018

Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model

Anfuso B, El-Khobar KE, Ie SI, Avellini C, Radillo O, Raseni A, Tiribelli C, Sukowati CHC

Sci Rep. 8(1):13168. doi: 10.1038/s41598-018-31406-5

2018

Serum stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma

Sukowati CHC, Patti R, Pascut D, Ladju RB, Tarchi P, Zanotta N, Comar C, Tiribelli C, Croce LS

Biomed Res Int. 2018:6435482. doi: 10.1155/2018/6435482

2018

Steato-Score: non-invasive quantitative assessment of liver fat by ultrasound imaging

Di Lascio N, Avigo C, Salvati A, MartiniN, Ragucci M, Monti S,Prinster A,Chiappino D, Mancini M,D'Elia D, Ghiadoni L,Bonino F, Brunetto MR, Faita F

Ultrasound Med Biol. 44(8):1585-1596. doi: 10.1016/j.ultrasmedbio.2018.03.011.

2018

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health

Martini D, Galli C, Guareschi C, Angelino D, Bedogni G, Biasini B, Zavaroni I, Pruneti C, Ventura M, Galli D, Mirandola P, Vitale M, Dei Cas A, Bonadonna RC, Passeri G, Del Rio D

NFS Journal 10:10-25

2018

Pagina 7 di 28

Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?

Bellarosa C, Vitek L, Tiribelli C

Clin Pharmacol Ther. Dec 27. doi: 10.1002/cpt.1341

2018

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. Jun;67(6):2072-2073. doi: 10.1002/hep.29753.

2018

A new stage in Annals of Hepatology

Panduro A, Tiribelli C, Chávez-Tapia NC, Uribe M

Ann Hepatol. 17(3):339-340. doi: 10.5604/01.3001.0011.7377.

2018

Where do we stand in the field of neonatal jaundice? Commentary on the 2017 J. Donald Osrow Trieste Yellow Retreat

Riordan S, Gazzin S

Pediatr Res. Jun;83(6):1090-1092. doi: 10.1038/pr.2018.53.

2018

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231

2018

Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643

2018

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359

2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V, Tiribelli C, Mastrotto F, Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027

2017

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. doi: 10.1002/hep.29753.

2017

Treatments for non-alcoholic steatohepatitis - still a long way to go

Rosso N, Tiribelli C

Aliment Pharmacol Ther. 2017 Oct;46(7):700-701. doi: 10.1111/apt.14247 (editorial)

2017

Pagina 4 di 9

Progetto Interreg C3B a "Sconfinamenti" - Radio RAIFVG

Nella puntata della trasmissione "Sconfinamenti" di Radio RAI FVG si parla del progetto Interreg Italia-Slovenia “C3B”: una biobanca transfrontaliera per prevenire malattie e favorire la medicina personalizzata. Guidato dalla Fondazione Italiana Fegato, il progetto è finanziato dal Fondo Europeo di Sviluppo Regionale e coinvolge importanti realtà del Friuli Venezia Giulia, del Veneto e della Slovenia.

V oddaji Radia RAI FVG "Trespassing" je omenjen projekt Interreg Italija-Slovenija "C3B": čezmejna biobanka za preprečevanje bolezni in promocijo personalizirane medicine. Projekt, ki ga vodi Italijanska fundacija za jetra, financira Evropski sklad za regionalni razvoj in vključuje pomembne realnosti Furlanije Julijske krajine, Veneta in Slovenije.

Ascolta l'intervista:

Poslušajte intervju:

Intervista a Sconfinamenti - RadioRAI FVG

Da RadioRAI Fvg
"Sconfinamenti"
Puntata 14/02/2022

Si parla del progetto Interreg Italia-Slovenia “C3B”: una biobanca transfrontaliera per prevenire malattie e favorire la medicina personalizzata. Guidato dalla Fondazione Italiana Fegato, il progetto è finanziato dal Fondo Europeo di Sviluppo Regionale e coinvolge importanti realtà del Friuli Venezia Giulia, del Veneto e della Slovenia.

Ascolta l'intervista:

The Liver Lab

Our friends

Nonalcoholic fatty liver disease: A wide spectrum disease

lcnRNA-mediated regulation of acquired chemoresistance in HCC

Heterogeneity of hepatic cancer stem cells

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Physiology of the liver

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Alcohol and nutrition as risk factors for chronic liver disease

Bilirubin metabolism and transport

Disturbances of bilirubin metabolism

Association of bright liver with the PNPLA3 I148M gene variant in 1-year-old toddlers

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma

Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

Bilirubin-induced oxidative stress leads to DNA damage in the cerebellum of hyperbilirubinemic neonatal mice and activates DNA double strand break repair pathways in human cells

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat

Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model

Serum stem cell growth factor beta for the prediction of therapy response in hepatocellular carcinoma

Steato-Score: non-invasive quantitative assessment of liver fat by ultrasound imaging

Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health

Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?

Two drinks per day does not take your fatty liver away

A new stage in Annals of Hepatology

Where do we stand in the field of neonatal jaundice? Commentary on the 2017 J. Donald Osrow Trieste Yellow Retreat

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Global epidemiology of NAFLD/NASH: what we need in the future

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Two drinks per day does not take your fatty liver away

Treatments for non-alcoholic steatohepatitis - still a long way to go

Membri promotori

Membri sostenitori

Membri aderenti

Supporters

News

Progetto Interreg C3B a "Sconfinamenti" - Radio RAIFVG

Press Review

Intervista a Sconfinamenti - RadioRAI FVG